Innoviva, Inc. (INVA): Revenue
$411.33M
Year ended 2025-12-31
$440.00M
Trailing 12 months to 2026-06-30
+7.5%
3-year compound annual growth
+4.1%
5-year compound annual growth
+22.5%
10-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $411.33M | +14.7% | 2026-02-25, From 2025-01-01 |
| 2024-12-31 | $358.71M | +15.5% | 2026-02-25, From 2024-01-01 |
| 2023-12-31 | $310.46M | -6.3% | 2026-02-25, From 2023-01-01 |
| 2022-12-31 | $331.34M | -15.4% | 2025-02-26, From 2022-01-01 |
| 2021-12-31 | $391.87M | +16.4% | 2024-03-05, From 2021-01-01 |
| 2020-12-31 | $336.79M | +29.0% | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | $261.02M | 0.0% | 2022-03-17, From 2019-01-01 |
| 2018-12-31 | $261.00M | +20.2% | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | $217.22M | +62.6% | 2020-02-19, From 2017-01-01 |
| 2016-12-31 | $133.57M | +147.6% | 2019-02-19, From 2016-01-01 |
| 2015-12-31 | $53.95M | +539.7% | 2018-02-23, From 2015-01-01 |
| 2014-12-31 | $8.43M | +86.1% | 2017-02-28, From 2014-01-01 |
| 2013-12-31 | $4.53M | -19.3% | 2016-02-24, From 2013-01-01 |
| 2012-12-31 | $5.61M | -77.1% | 2015-02-27, From 2012-01-01 |
| 2011-12-31 | $24.51M | +1.2% | 2014-03-03, From 2011-01-01 |
| 2010-12-31 | $24.22M | -0.6% | 2013-02-26, From 2010-01-01 |
| 2009-12-31 | $24.37M | n/a | 2012-02-27, From 2009-01-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| Innoviva, Inc. (INVA) | 2025-12-31 | $411.33M | +14.7% |
| Ardelyx, Inc. (ARDX) | 2025-12-31 | $407.32M | +22.1% |
| Sinovac Biotech Ltd (SVA) | 2025-12-31 | $386.01M | +6.8% |
| Arcutis Biotherapeutics, Inc. (ARQT) | 2025-12-31 | $372.07M | +123.4% |
| Zai Lab Ltd (ZLAB) | 2025-12-31 | $457.18M | +15.0% |
| Nature's Sunshine Products Inc (NATR) | 2025-12-31 | $480.14M | +5.7% |
| MannKind Corp (MNKD) | 2025-12-31 | $348.97M | +22.2% |
| Travere Therapeutics, Inc. (TVTX) | 2025-12-31 | $490.73M | +110.5% |
| BridgeBio Pharma, Inc. (BBIO) | 2025-12-31 | $502.08M | +126.3% |
Compare INVA, ARDX, SVA, ARQT side by side · Screen every company in Pharmaceutical Preparations ↗